ATE510839T1 - Benzofuropyrimidinone als proteinkinase-hemmer - Google Patents
Benzofuropyrimidinone als proteinkinase-hemmerInfo
- Publication number
- ATE510839T1 ATE510839T1 AT08832770T AT08832770T ATE510839T1 AT E510839 T1 ATE510839 T1 AT E510839T1 AT 08832770 T AT08832770 T AT 08832770T AT 08832770 T AT08832770 T AT 08832770T AT E510839 T1 ATE510839 T1 AT E510839T1
- Authority
- AT
- Austria
- Prior art keywords
- benzofuropyrimidinone
- protein kinase
- kinase inhibitor
- inhibitor
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US890707P | 2007-12-21 | 2007-12-21 | |
US7097108P | 2008-03-25 | 2008-03-25 | |
PCT/US2008/087939 WO2009086264A1 (en) | 2007-12-21 | 2008-12-22 | Benzofuropyrimidinones as protein kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE510839T1 true ATE510839T1 (de) | 2011-06-15 |
Family
ID=40383673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT08832770T ATE510839T1 (de) | 2007-12-21 | 2008-12-22 | Benzofuropyrimidinone als proteinkinase-hemmer |
Country Status (20)
Country | Link |
---|---|
US (1) | US20090247559A1 (de) |
EP (1) | EP2097419B1 (de) |
JP (1) | JP2011507908A (de) |
KR (1) | KR20100098714A (de) |
CN (1) | CN101965351A (de) |
AR (1) | AR069869A1 (de) |
AT (1) | ATE510839T1 (de) |
AU (1) | AU2008345560A1 (de) |
BR (1) | BRPI0821573A2 (de) |
CA (1) | CA2712358A1 (de) |
CL (1) | CL2008003873A1 (de) |
CO (1) | CO6321258A2 (de) |
EA (1) | EA019785B1 (de) |
IL (1) | IL206416A0 (de) |
MX (1) | MX2010006799A (de) |
NZ (1) | NZ586936A (de) |
PE (1) | PE20091669A1 (de) |
TW (1) | TW200930375A (de) |
WO (1) | WO2009086264A1 (de) |
ZA (1) | ZA201004243B (de) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102007026341A1 (de) | 2007-06-06 | 2008-12-11 | Merck Patent Gmbh | Benzoxazolonderivate |
DE102007032507A1 (de) | 2007-07-12 | 2009-04-02 | Merck Patent Gmbh | Pyridazinonderivate |
DE102007061963A1 (de) | 2007-12-21 | 2009-06-25 | Merck Patent Gmbh | Pyridazinonderivate |
DE102008019907A1 (de) | 2008-04-21 | 2009-10-22 | Merck Patent Gmbh | Pyridazinonderivate |
DE102008028905A1 (de) | 2008-06-18 | 2009-12-24 | Merck Patent Gmbh | 3-(3-Pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazinderivate |
CA2744987C (en) | 2008-12-02 | 2018-01-16 | Chiralgen, Ltd. | Method for the synthesis of phosphorus atom modified nucleic acids |
KR101663335B1 (ko) | 2008-12-22 | 2016-10-06 | 메르크 파텐트 게엠베하 | 6-(1-메틸-1h-피라졸-4-일)-2-{3-[5-(2-모르폴린-4-일-에톡시)-피리미딘-2-일]-벤질}-2h-피리다진-3-온디히드로겐포스페이트의 신규한 다형체 및 이의 제조 방법 |
BR112012000828A8 (pt) | 2009-07-06 | 2017-10-10 | Ontorii Inc | Novas pró-drogas de ácido nucleico e métodos de uso das mesmas |
US10428019B2 (en) | 2010-09-24 | 2019-10-01 | Wave Life Sciences Ltd. | Chiral auxiliaries |
RU2014105311A (ru) | 2011-07-19 | 2015-08-27 | Уэйв Лайф Сайенсес Пте. Лтд. | Способы синтеза функционализованных нуклеиновых кислот |
JP6268157B2 (ja) | 2012-07-13 | 2018-01-24 | 株式会社Wave Life Sciences Japan | 不斉補助基 |
MX356830B (es) | 2012-07-13 | 2018-06-15 | Shin Nippon Biomedical Laboratories Ltd | Adyuvante de acido nucleico quiral. |
SG10201912895PA (en) | 2012-07-13 | 2020-02-27 | Wave Life Sciences Ltd | Chiral control |
CN102875558A (zh) * | 2012-11-05 | 2013-01-16 | 贵州大学 | 2-氯-4-取代-8-硝基苯并呋喃[3,2-d]嘧啶类化合物及其制备方法和用途 |
CN103044370A (zh) * | 2012-12-28 | 2013-04-17 | 山东邹平大展新材料有限公司 | 一种5-(哌嗪-1-基)苯并呋喃-2-甲酰胺的制备方法 |
CN104045642B (zh) * | 2013-03-14 | 2016-08-24 | 上海医药工业研究院 | 含嘧啶或吡啶的稠环化合物及其作为抗肿瘤药物的应用 |
JPWO2015108047A1 (ja) | 2014-01-15 | 2017-03-23 | 株式会社新日本科学 | 免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤 |
JPWO2015108046A1 (ja) | 2014-01-15 | 2017-03-23 | 株式会社新日本科学 | 抗アレルギー作用を有するキラル核酸アジュバンド及び抗アレルギー剤 |
WO2015108048A1 (ja) | 2014-01-15 | 2015-07-23 | 株式会社新日本科学 | 抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤 |
KR102423317B1 (ko) | 2014-01-16 | 2022-07-22 | 웨이브 라이프 사이언시스 리미티드 | 키랄 디자인 |
JP6569908B2 (ja) | 2014-01-31 | 2019-09-04 | カルナバイオサイエンス株式会社 | 抗がん剤組成物 |
US9676757B2 (en) | 2014-02-27 | 2017-06-13 | Merck Patent Gmbh | Heterocyclic compounds as NaV channel inhibitors and uses thereof |
WO2015152319A1 (ja) * | 2014-04-02 | 2015-10-08 | 株式会社 三和化学研究所 | 5,7-無置換-ピラゾロ[1,5-a]ピリミジン-6-カルボン酸の製造方法 |
KR101837565B1 (ko) | 2014-08-06 | 2018-03-12 | 삼성에스디아이 주식회사 | 유기 화합물, 유기 광전자 소자 및 표시 장치 |
JP6840931B2 (ja) * | 2015-03-09 | 2021-03-10 | 東ソー株式会社 | 縮環芳香族化合物の製造方法 |
US11020396B2 (en) | 2016-11-08 | 2021-06-01 | Cancer Research Technology Limited | Pyrimidinone derivatives as Cdc7 inhibitors |
NL2021185B1 (en) | 2018-06-26 | 2020-01-06 | Stichting Het Nederlands Kanker Inst Antoni Van Leeuwenhoek Ziekenhuis | Combination Therapy and Use Thereof for Treating Cancer |
JP7399968B2 (ja) | 2018-09-25 | 2023-12-18 | インサイト・コーポレイション | Alk2及び/またはfgfr調節剤としてのピラゾロ[4,3-d]ピリミジン化合物 |
CN111689947B (zh) * | 2019-03-13 | 2023-07-14 | 鲁南制药集团股份有限公司 | 替加氟-l-脯氨酸共晶体及其制备方法 |
CA3164707A1 (en) * | 2020-02-03 | 2021-08-12 | Ana Maria Garcia Collazo | Combination therapy for treating mps1 |
WO2021198191A1 (en) | 2020-03-30 | 2021-10-07 | Enyo Pharma | Quinazolinone derivatives and uses thereof for treating a cancer |
AR123684A1 (es) * | 2020-10-05 | 2023-01-04 | Japan Tobacco Inc | Compuesto de tetrahidrobenzofurodiazepinona y uso farmacéutico del mismo |
US20240092783A1 (en) | 2021-03-18 | 2024-03-21 | Merck Patent Gmbh | Heteroaromatic compounds for organic electroluminescent devices |
WO2023156386A2 (en) * | 2022-02-16 | 2023-08-24 | Duke Street Bio Limited | Pharmaceutical compound |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL112248A0 (en) * | 1994-01-25 | 1995-03-30 | Warner Lambert Co | Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them |
JPWO2002051849A1 (ja) | 2000-12-26 | 2004-04-22 | 第一製薬株式会社 | Cdk4活性阻害剤 |
CA2444598A1 (en) * | 2001-04-20 | 2003-10-31 | Vertex Pharmaceuticals Incorporated | Compositions useful as inhibitors of gsk-3 |
US7345046B2 (en) | 2003-05-30 | 2008-03-18 | Chiron Corporation | Heteroaryl-fused pyrimidinyl compounds as anticancer agents |
WO2006023381A1 (en) * | 2004-08-16 | 2006-03-02 | Taigen Biotechnology | Pyrimidinone compounds |
EP1776982A1 (de) | 2005-10-18 | 2007-04-25 | Argenta Discovery Limited | Pyrimidine Derivate als Modulator der Histamine Rezeptor |
US20080269239A1 (en) | 2004-11-11 | 2008-10-30 | Argenta Discovery Ltd. | Pyrimidine Compounds as Histamine Modulators |
-
2008
- 2008-12-19 TW TW097149655A patent/TW200930375A/zh unknown
- 2008-12-19 PE PE2008002147A patent/PE20091669A1/es not_active Application Discontinuation
- 2008-12-19 AR ARP080105615A patent/AR069869A1/es unknown
- 2008-12-22 EA EA201070786A patent/EA019785B1/ru not_active IP Right Cessation
- 2008-12-22 BR BRPI0821573A patent/BRPI0821573A2/pt not_active IP Right Cessation
- 2008-12-22 JP JP2010539930A patent/JP2011507908A/ja not_active Ceased
- 2008-12-22 KR KR1020107016179A patent/KR20100098714A/ko not_active Application Discontinuation
- 2008-12-22 CA CA2712358A patent/CA2712358A1/en not_active Abandoned
- 2008-12-22 CL CL2008003873A patent/CL2008003873A1/es unknown
- 2008-12-22 AT AT08832770T patent/ATE510839T1/de not_active IP Right Cessation
- 2008-12-22 MX MX2010006799A patent/MX2010006799A/es active IP Right Grant
- 2008-12-22 EP EP08832770A patent/EP2097419B1/de active Active
- 2008-12-22 AU AU2008345560A patent/AU2008345560A1/en not_active Abandoned
- 2008-12-22 CN CN2008801272275A patent/CN101965351A/zh active Pending
- 2008-12-22 NZ NZ586936A patent/NZ586936A/en not_active IP Right Cessation
- 2008-12-22 US US12/341,210 patent/US20090247559A1/en not_active Abandoned
- 2008-12-22 WO PCT/US2008/087939 patent/WO2009086264A1/en active Application Filing
-
2010
- 2010-06-15 ZA ZA2010/04243A patent/ZA201004243B/en unknown
- 2010-06-16 IL IL206416A patent/IL206416A0/en unknown
- 2010-07-21 CO CO10088575A patent/CO6321258A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MX2010006799A (es) | 2010-10-05 |
EP2097419B1 (de) | 2011-05-25 |
BRPI0821573A2 (pt) | 2016-08-09 |
TW200930375A (en) | 2009-07-16 |
EA019785B1 (ru) | 2014-06-30 |
WO2009086264A1 (en) | 2009-07-09 |
EP2097419A1 (de) | 2009-09-09 |
EA201070786A1 (ru) | 2011-02-28 |
KR20100098714A (ko) | 2010-09-08 |
CO6321258A2 (es) | 2011-09-20 |
JP2011507908A (ja) | 2011-03-10 |
AU2008345560A1 (en) | 2009-07-09 |
US20090247559A1 (en) | 2009-10-01 |
CN101965351A (zh) | 2011-02-02 |
PE20091669A1 (es) | 2009-12-06 |
AR069869A1 (es) | 2010-02-24 |
CL2008003873A1 (es) | 2009-06-26 |
NZ586936A (en) | 2012-07-27 |
ZA201004243B (en) | 2011-03-30 |
CA2712358A1 (en) | 2009-07-09 |
IL206416A0 (en) | 2010-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE510839T1 (de) | Benzofuropyrimidinone als proteinkinase-hemmer | |
CY2019009I2 (el) | Αναστολεις πρωτεϊνικων κινασων | |
CY2017016I1 (el) | Αναστολεις πρωτεασωματος | |
ATE479434T1 (de) | Als protein-kinase-inhibitoren nutzbare dyhydrodiazepine | |
DK2041138T3 (da) | Pyrroltriazinkinase-inhibitorer | |
DK2024375T3 (da) | Cyclopropyl-kondenserede indolobenzazepin-HCV-NS5B-hæmmere | |
DK2215092T3 (da) | Substitueret piperidino-dihydrothienopyrimidin | |
BRPI0910668A2 (pt) | inibidores de proteína quinases | |
DE602006004717D1 (de) | Kapselperforationsmodul | |
DE602007012130D1 (de) | Modifizierte flavin-adenin-dinucleotid-abhängige glucose-dehydrogenase | |
ATE506358T1 (de) | 2-benzylpyridazinonderivate als met-kinasehemmer | |
ATE524477T1 (de) | Aziridinylepothilonverbindungen | |
AT504580A3 (de) | Scan-einrichtung | |
DE602006019150D1 (de) | Riemenscheibenanorndung | |
ATE546437T1 (de) | Aminomethyl-4-imidazole | |
DE502007000218D1 (de) | nsetzungen | |
DE502007002453D1 (de) | Kunstoffverdichtergehäuse | |
DE602006016174D1 (de) | Blisterverpackungsverfahren | |
ATE534010T1 (de) | Zielfernrohr | |
ITMI20060943A1 (it) | Nessuno | |
BRPI0921509A2 (pt) | inibidor triazolotiadiazol de proteína quinase c-met | |
DE502007001629D1 (de) | Rfahren | |
DK2066662T3 (da) | Serinhydrolaseinhibitorer | |
DE102006045567A8 (de) | Crimpstabilisierung | |
DE112007003147A5 (de) | Rohr-Biegevorrichtung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |